Sodium-glucose co-transporter-2 inhibitors reduce the risk of new-onset stroke in patients with type 2 diabetes: A population-based cohort study

RT @DanielJDrucker: In multiple RCTs #T2D where confounding is minimized, SGLT2i do not reduce the rates of new stroke-yet in the real worl…

What type of “stroke”? Correlation versus causation. Done incorrectly. Many potential confounding variables.

In multiple RCTs #T2D where confounding is minimized, SGLT2i do not reduce the rates of new stroke-yet in the real world, where PPL at risk for stroke may not be treated with SGLT2i, well, a different story emerges. Choose your science wisely https://t.co/

RT @FrontCVMedicine: New Research: Sodium-glucose co-transporter-2 inhibitors reduce the risk of new-onset stroke in patients with type 2 d…